From clinical trial registrations to regulatory actions, IR calls to conference readouts — most pharma teams are still finding out about competitor moves days after they matter. We built IntelXion™ to close that gap permanently.
Competitive intelligence in pharma isn't just about tracking trial registries. It's about understanding what your competitors are doing commercially — their messaging, their pipeline priorities, their IR narrative, their conference presence, their regulatory moves — and connecting all of that into a coherent picture your brand team can actually act on. IntelXion™ is the platform that makes that possible. It continuously monitors six pillars of competitive intelligence, processes signals through a combination of NLP and large language models, and delivers structured intelligence in hours — not days or weeks.
We cover the conferences that matter to your indication. Pre-conference abstract screening flags relevant data before you arrive. Live session monitoring captures key readouts in real time. Post-conference competitive summary decks land within 48 hours — with pipeline implications and messaging analysis, not just a list of abstracts.
Approvals, CRLs, PDUFA dates, AdCom meetings, label changes, new indications, REMS updates — monitored across FDA, EMA, Health Canada and major global agencies. We also track IRA drug pricing negotiation signals, breakthrough and fast track designations, and FDA warning letters that affect your competitive landscape. If something regulatory happens that matters to your brand, you'll know about it the same day.
Your competitors tell their investors exactly where their priorities lie. Most pharma commercial teams aren't listening. We monitor competitor earnings calls and investor day presentations in real time. Our NLP engine extracts pipeline priority signals, guidance changes, strategic intent and commercial commentary. Flash summaries land within two hours of a call completing — with specific implications highlighted for your brand and indication.
We build and continuously update disease-area competitive landscape reports for your indication. Full pipeline mapping from Phase 1 through commercialized assets. Endpoint comparison matrices. Competitor trial timelines. Launch readiness signals. SoV benchmarking. The landscape isn't a quarterly deliverable — it updates automatically as new signals come in.
Press releases, trade press, patent filings, M&A activity, licensing deals, key leadership changes — monitored continuously across FiercePharma, Endpoints News, BioPharma Dive, SEC filings and wire services. We surface the signals that matter to your commercial strategy and filter out the noise.
KOL and DOL activity on LinkedIn and X/Twitter. HCP online conversations by indication. Competitor digital advertising activity. Congress social buzz. Competitor website content changes. This is early signal detection — the kind of intelligence that shows up in your competitive landscape three months before it appears in any published report.
Connect AI connectors auto-sync with ClinicalTrials.gov, EU-CTR, WHO ICTRP, FDA, SEC/EDGAR, PubMed and major conference abstract databases. Daily automated refresh.
Extract Our NLP engine parses each data source — extracting trial phase, indication, molecule, endpoints, patient population, sponsor and commercial signals. Language models summarize IR call transcripts and news in commercial context.
Analyze AI builds and continuously updates your competitive landscape — pipeline timelines, endpoint benchmarks, IR call sentiment scoring and conference readout tracking.
Deliver Deliver Intelligence delivered via live dashboard, real-time alert system, automated digests and export-ready reports. Post-conference decks built automatically. Everything searchable.
A mid-size oncology company was 12 months from launch, manually tracking 8 competitors across spreadsheets and Google alerts. Within the first month on IntelXion™ they identified a competitor accelerating their Phase 3 completion by 6 months — four months before any industry publication reported it. The commercial team re-sequenced their launch messaging in response.
A lean medical affairs team needed full ASCO coverage across 3 indications. IntelXion™ pre-screened 2,400+ abstracts and flagged 34 relevant ones before the conference started. Post-ASCO competitive summary delivered within 48 hours. The brand director had a full competitive readout before returning from the conference.
Powered by IntelXion™ · ClinicalXion™ (clinical AI engine)
Request a demo